semaglutide news october 26 2025 Americans turn to risky unregulated sellers for GLP-1 weight-loss drugs Semaglutide: The Drug of Today

First-time prescribing of ADMs decreased in June 2024, relative to March 2024 (-19.71%)

Because of semaglutide and tirzepatide shortages, which have forced patients to involuntarily stop and restart treatment, reliable data on adherence for GLP-1s is not yet available

Primarily, research tells us that, An intermittent lack of diet adherence is a major contributor to the frequently observed early weight-loss plateau. But adherence issues may not fully explain why youre plateauing in weight loss on semaglutide

Your Health, Your Terms Start Feeling Like Yourself Again Get your free practice guide and a $100 voucher toward your first visit

Barcelona, Spain)